Evidence map›Paper›PMID 35413917›Full record

ArticleImplementation science : IS2022

Revisiting concepts of evidence in implementation science.

Ross C Brownson, Rachel C Shelton, Elvin H Geng, Russell E Glasgow

Abstract read
In one paragraph

Article in Implementation science : IS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Tailored interventions to address determinants of practice.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Methodological considerations for evaluating scale-up programmes in healthcare: a methods review.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ross C BrownsonPrevention Research Center, Brown School at Washington University in St. Louis, One Brookings Drive, Campus, Box 1196, St. Louis, MO, 63130, USA. rbrownson@wustl.edu.ORCID 0000-0003-4260-2205
Rachel C SheltonDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, NY, 10032, USA.
Elvin H GengDivision of Infectious Diseases, Department of Medicine and Center for Dissemination and Implementation in the Institute for Public Health, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Russell E GlasgowDepartment of Family Medicine and Adult & Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
Washington University Center for Diabetes Translation Research P30DK092950 · NIDDK · WASHINGTON UNIVERSITY · PI Ross C Brownson, Debra Haire-Joshu · 2011 to 2026
$11.7M
Washington University Implementation Science Center for Cancer Control (WU-ISCCC)P50CA244431 · NCI · WASHINGTON UNIVERSITY · PI COLDITZ, GRAHAM A. · 2019 to 2023
$8.0M
Research ProgramP50CA244690 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BEIDAS, RINAD SARY · 2020 to 2024
$4.9M
Pragmatic Implementation Science Approaches to Assess and Enhance Value of Cancer Prevention and Control in Rural Primary CareP50CA244688 · NCI · UNIVERSITY OF COLORADO DENVER · PI GLASGOW, RUSSELL E · 2019 to 2023
$4.9M
De-implementation of Mammography Overuse in Primary Care SettingsR01CA255382 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MOISE, NATHALIE, SHELTON, RACHEL C · 2021 to 2025
$2.6M
Mentored Education for Dissemination and Implementation Science (MEDIS) ProgramR25DK123008 · NIDDK · WASHINGTON UNIVERSITY · PI BROWNSON, ROSS C, HAIRE-JOSHU, DEBRA · 2020 to 2024
$1.1M
ACL HHS U48DP006395NCCDPHP CDC HHS U48 DP006395NCI NIH HHS P50 CA244431NCI NIH HHS P50 CA244688NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30 DK092950NIDDK NIH HHS R25 DK123008NIH HHS P30DK092950NIH HHS P50CA244431NIH HHS P50CA244688NIH HHS P50CA244690NIH HHS R01CA255382NIH HHS R25DK123008
6 · The paper itself

Abstract

backgroundEvidence, in multiple forms, is a foundation of implementation science. For public health and clinical practice, evidence includes the following: type 1 evidence on etiology and burden; type 2 evidence on effectiveness of interventions; and type 3: evidence on dissemination and implementation (D&I) within context. To support a vision for development and use of evidence in D&I science that is more comprehensive and equitable (particularly for type 3 evidence), this article aims to clarify concepts of evidence, summarize ongoing debates about evidence, and provide a set of recommendations and tools/resources for addressing the "how-to" in filling evidence gaps most critical to advancing implementation science. MAIN TEXT: Because current conceptualizations of evidence have been relatively narrow and insufficiently characterized in our opinion, we identify and discuss challenges and debates about the uses, usefulness, and gaps in evidence for implementation science. A set of questions is proposed to assist in determining when evidence is sufficient for dissemination and implementation. Intersecting gaps include the need to (1) reconsider how the evidence base is determined, (2) improve understanding of contextual effects on implementation, (3) sharpen the focus on health equity in how we approach and build the evidence-base, (4) conduct more policy implementation research and evaluation, and (5) learn from audience and stakeholder perspectives. We offer 15 recommendations to assist in filling these gaps and describe a set of tools for enhancing the evidence most needed in implementation science.

conclusionsTo address our recommendations, we see capacity as a necessary ingredient to shift the field's approach to evidence. Capacity includes the "push" for implementation science where researchers are trained to develop and evaluate evidence which should be useful and feasible for implementers and reflect community or stakeholder priorities. Equally important, there has been inadequate training and too little emphasis on the "pull" for implementation science (e.g., training implementers, practice-based research). We suggest that funders and reviewers of research should adopt and support a more robust definition of evidence. By critically examining the evolving nature of evidence, implementation science can better fulfill its vision of facilitating widespread and equitable adoption, delivery, and sustainment of scientific advances.

Indexed as

Health EquityImplementation ScienceHumansResearch PersonnelContextEquityEvidenceImplementation science

Identifiers

PMID35413917
PMCPMC9004065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.